Yunpeng DONG, Yuan CHENG, Jin CHEN. Effects of silencing APN gene on proliferation, invasion and apoptosis of human glioma U251 cells[J]. Journal of Third Military Medical University, 2020, 42(9): 908-914.
DOI:
Yunpeng DONG, Yuan CHENG, Jin CHEN. Effects of silencing APN gene on proliferation, invasion and apoptosis of human glioma U251 cells[J]. Journal of Third Military Medical University, 2020, 42(9): 908-914. DOI: 10.16016/j.1000-5404.201912238.
Effects of silencing APN gene on proliferation, invasion and apoptosis of human glioma U251 cells
To determine the effect of aminopeptidase N (APN) on the proliferation
invasion
and apoptosis in human glioma U251 cells and to investigate the possible mechanism.
Methods
2
After APN gene expression was silenced in glioma cells U251 by RNAi
its expression at mRNA and protein levels was detected by RT-qPCR and Western blotting
respectively. Then
CCK-8 assay
flow cytometry
wound healing test and transwell assay were used to detect the proliferation ability
cell cycle and apoptosis
migration and invasion activity in the U251 cells. The protein expression of STAT3 signal pathway proteins t-STAT3
p-STAT3
MMP-2 and Bcl-2 was measured by Western blotting.
Results
2
Compared with blank control and NC-siRNA cells
the expression of APN was decreased at mRNA and protein levels in APN-siRNA cells (
P
<
0.01). Silencing of APN gene also
resulted in inhibited proliferation ability (
P
<
0.05)
cell cycle arrested at G
0
/G
1
phase
enhanced apoptotic rate (
P
<
0.01)
and decreased migration and invasion abilities (
P
<
0.01) in U251 cells. What's more
the inhibited expression of p-STAT3 caused the decreased expression of Bcl-2 and MMP-2 (all
P
<
0.05).
Conclusion
2
Silencing of APN could inhibit the proliferation
migration and invasion
and induce apoptosis in glioma U251 cells
via
STAT3 signaling pathway.
关键词
Keywords
references
DIXON J, KAKLAMANIS L, TURLEY H, et al . Expression of aminopeptidase-n (CD 13) in normal tissues and malignant neoplasms of epithelial and lymphoid origin[J ] . J Clin Pathol, 1994, 47(1): 43-47. DOI:10.1136/jcp.47.1.43.
RESHEQ Y J, MENZNER A K, BOSCH J, et al . Impaired transmigration of myeloid-derived suppressor cells across human sinusoidal endothelium is associated with decreased expression of CD13[J ] . J Immunol, 2017, 199(5): 1672-1681. DOI:10.4049/jimmunol.1600466.
YAMANAKA C, WADA H, EGUCHI H, et al . Clinical significance of CD13 and epithelial mesenchymal transition (EMT) markers in hepatocellular carcinoma[J ] . Jpn J Clin Oncol, 2018, 48(1): 52-60. DOI:10.1093/jjco/hyx157.
MARTÍNEZ J M, PRIETO I, RAMÍREZ M J, et al . Aminopeptidase activities in breast cancer tissue[J ] . Clin Chem, 1999, 45(10): 1797-1802. DOI:10.1093/clinchem/45.10.1797.
ISHⅡ K, USUI S, SUGIMURA Y, et al . Aminopeptidase N regulated by zinc in human prostate participates in tumor cell invasion[J ] . Int J Cancer, 2001, 92(1): 49-54.
ZHANG J, FANG C Y, QU M H, et al . CD13 inhibition enhances cytotoxic effect of chemotherapy agents[J ] . Front Pharmacol, 2018, 9: 1042. DOI:10.3389/fphar.2018.01042.
AFFRONTI M L, HEERY C R, HERNDON J E 2nd, et al . Overall survival of newly diagnosed glioblastoma patients receiving carmustine wafers followed by radiation and concurrent temozolomide plus rotational multiagent chemotherapy[J ] . Cancer, 2009, 115(15): 3501-3511. DOI:10.1002/cncr.24398.
LIAO A H, CHOU H Y, HSIEH Y L, et al . Enhanced therapeutic epidermal growth factor receptor (EGFR) antibody delivery via pulsed ultrasound with targeting microbubbles for glioma treatment[J ] . J Med Biol Eng, 2015, 35(2): 156-164. DOI:10.1007/s40846-015-0032-9..
WELLER M, WICK W, ALDAPE K, et al . Glioma[J ] . Nat Rev Dis Primers, 2015, 1: 15017. DOI:10.1038/nrdp.2015.17.
HAMID O, ROBERT C, DAUD A, et al . Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma[J ] . N Engl J Med, 2013, 369(2):134-144. DOI: 10.1056/NEJMoa1305133.
BALAR A V, WEBER J S. PD-1 and PD-L1 antibodies in cancer: current status and future directions[J]. Cancer Immunol Immunother, 2017, 66(5): 551-564. DOI:10.1007/s00262-017-1954-6.
FILLEY A C, HENRIQUEZ M, DEY M. Recurrent glioma clinical trial, CheckMate-143: the game is not over yet[J]. Oncotarget, 2017, 8(53): 91779-91794. DOI:10.18632/oncotarget.21586.
GRUPP S A, KALOS M, BARRETT D, et al . Chimeric antigen receptor-modified T cells for acute lymphoid leukemia[J ] . N Engl J Med, 2013, 368(16): 1509-1518. DOI:10.1056/NEJMoa1215134.
SCHUSTER S J, SVOBODA J, CHONG E A, et al . Chimeric antigen receptor T cells in refractory B-cell lymphomas[J ] . N Engl J Med, 2017, 377(26): 2545-2554. DOI:10.1056/nejmoa1708566.
WEI X R, LAI Y X, LI J, et al . PSCA and MUC1 in non-small-cell lung cancer as targets of chimeric antigen receptor T cells[J ] . Oncoimmunology, 2017, 6(3): e1284722. DOI:10.1080/2162402x.2017.1284722.
HECKLER M, DOUGAN S K. Unmasking pancreatic cancer: epitope spreading after single antigen chimeric antigen receptor T-cell therapy in a human phase Ⅰ trial[J]. Gastroenterology, 2018, 155(1): 11-14. DOI:10.1053/j.gastro.2018.06.023.
CHEN F, ZHENG X H, LI W B. Immunotherapy for the treatment of glioma[J]. J Cap Med Univ, 2019, 40(6): 966-971.
PIEDFER M, DAUZONNE D, TANG R P, et al . Aminopeptidase-N/CD13 is a potential proapoptotic target in human myeloid tumor cells[J ] . FASEB J, 2011, 25(8): 2831-2842. DOI:10.1096/fj.11-181396.
WANG X Q, LIU Y, LIU W, et al . Ubenimex, an APN inhibitor, could serve as an antitumor drug in RT112 and 5637 cells by operating in an Aktassociated manner[J ] . Mol Med Rep, 2018, 17: 4531-4539. DOI:10.3892/mmr.2018.8402.
TERAUCHI M, KAJIYAMA H, SHIBATA K, et al . Inhibition of APN/CD13 leads to suppressed progressive potential in ovarian carcinoma cells[J ] . BMC Cancer, 2007, 7: 140. DOI:10.1186/1471-2407-7-140.
WANG R, SUN Q, WANG P, et al . Notch and Wnt/β-catenin signaling pathway play important roles in activating liver cancer stem cells[J ] . Oncotarget, 2016, 7(5): 5754-5768. DOI:10.18632/oncotarget.6805.
SAIKI I, FUJⅡ H, YONEDA J, et al . Role of aminopeptidase N (CD13) in tumor-cell invasion and extracellular matrix degradation[J ] . Int J Cancer, 1993, 54(1): 137-143. DOI:10.1002/ijc.2910540122.
BRANTLEY E C, BENVENISTE E N. Signal transducer and activator of transcription-3: a molecular hub for signaling pathways in gliomas[J]. Mol Cancer Res, 2008, 6(5): 675-684. DOI:10.1158/1541-7786.mcr-07-2180.